McDonald's makes solid debut on Jasdaq market

McDonald's makes solid debut on Jasdaq market

TOKYO, Japan - Den Fujita, president of McDonald's Co. (Japan) Ltd., speaks at a news conference July 26 in Tokyo following his company's solid debut on the Jasdaq over-the-counter market the same day. Boosted by popularity among individual investors, shares in the Japanese unit of the U.S. fast-food giant fetched 4,700 yen, 9% higher than its IPO price of 4,300 yen.

  • Product Code
  • ILEA001085342
  • Registered date
  • 2001/7/26 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • 2001 Kyodo News
  • Media size
  • 1864 × 1679 pixel
  • Resolution
  • dpi
  • Deployment size
  • 1.66(MB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    Japanese chipmaker Kioxia President Hayasaka

    Japanese chipmaker Kioxia President Hayasaka

    Japanese chipmaker Kioxia Holdings Corp. President Nobuo Hayasaka speaks during a press conference in Tokyo on Dec. 18, 2024, after his company debuted on the TSE's top-tier Prime Market the same day, closing over 10 percent above its initial offering price in Japan's second-largest listing this year.
      Japanese chipmaker Kioxia President Hayasaka

      Japanese chipmaker Kioxia President Hayasaka

      Japanese chipmaker Kioxia Holdings Corp. President Nobuo Hayasaka speaks during a press conference in Tokyo on Dec. 18, 2024, after his company debuted on the TSE's top-tier Prime Market the same day, closing over 10 percent above its initial offering price in Japan's second-largest listing this year.
        Japanese chipmaker Kioxia President Hayasaka

        Japanese chipmaker Kioxia President Hayasaka

        Japanese chipmaker Kioxia Holdings Corp. President Nobuo Hayasaka speaks during a press conference in Tokyo on Dec. 18, 2024, after his company debuted on the TSE's top-tier Prime Market the same day, closing over 10 percent above its initial offering price in Japan's second-largest listing this year.

          Japanese chipmaker Kioxia President Hayasaka

          TOKYO, Japan, Dec. 18 Kyodo - Japanese chipmaker Kioxia Holdings Corp. President Nobuo Hayasaka speaks during a press conference in Tokyo on Dec. 18, 2024, after his company debuted on the TSE's top-tier Prime Market the same day, closing over 10 percent above its initial offering price in Japan's second-largest listing this year. (Kyodo)
            Japanese chipmaker Kioxia President Hayasaka

            Japanese chipmaker Kioxia President Hayasaka

            Japanese chipmaker Kioxia Holdings Corp. President Nobuo Hayasaka speaks during a press conference in Tokyo on Dec. 18, 2024, after his company debuted on the TSE's top-tier Prime Market the same day, closing over 10 percent above its initial offering price in Japan's second-largest listing this year.
              U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

              U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

              Japanese pharmaceutical maker Eisai Co. CEO Haruo Naito holds a press conference in Tokyo on Jan. 7, 2023, a day after the U.S. Food and Drug Administration approved lecanemab, an Alzheimer's drug developed by his company and U.S. firm Biogen Inc. for treatment in the early stage of the fatal, brain-robbing disease.
                U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

                U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

                Japanese pharmaceutical maker Eisai Co. CEO Haruo Naito holds a press conference in Tokyo on Jan. 7, 2023, a day after the U.S. Food and Drug Administration approved lecanemab, an Alzheimer's drug developed by his company and U.S. firm Biogen Inc. for treatment in the early stage of the fatal, brain-robbing disease.
                  U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

                  U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

                  Japanese pharmaceutical maker Eisai Co. CEO Haruo Naito holds a press conference in Tokyo on Jan. 7, 2023, a day after the U.S. Food and Drug Administration approved lecanemab, an Alzheimer's drug developed by his company and U.S. firm Biogen Inc. for treatment in the early stage of the fatal, brain-robbing disease.
                    Dollar moves closer to 120 yen line

                    Dollar moves closer to 120 yen line

                    TOKYO, Japan - An electric board at Gaitame.com Co., a money market brokerage company, in Tokyo shows the U.S. dollar hitting just below the 120 yen line on Dec. 4, 2014. The dollar moved between 119.75 yen and 119.97 yen during the day, its highest level in about seven years and four months, changing hands most frequently at 119.90 yen.
                      Softbank cuts profit forecast

                      Softbank cuts profit forecast

                      TOKYO, Japan - Masayoshi Son (R), president of Softbank Corp., announces the company's earnings forecast for fiscal 2014 at a press conference in Tokyo on Nov. 4, 2014. Softbank cut its group operating profit forecast for the year through March 2015 to 900 billion yen from 1 trillion yen, citing a slump at its U.S. mobile unit Sprint Corp.